No Data
No Data
April 25 Repurchase Collection | Hang Seng Bank, Swire Group A and others bought back one after another. Of these, Hang Seng Bank spent HK$61.109 million
According to documents disclosed by the Hong Kong Stock Exchange on April 26, $Hang Seng Bank (00011.HK) $ and $Swire Group A (00019.HK) $ repurchased shares. ① $Hang Seng Bank (00011.HK) $ repurchased 600,000 common shares on April 25, involving an amount of HK$61.1091 million. The repurchase price per share ranged from HK$102.3 to HK$100.1. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 5.714 million shares, accounting for 0.299% of the number of shares issued when the ordinary resolution was passed. ② $
Featured announcements | CNOOC's net profit for the first quarter was nearly 40 billion yuan; China Aluminum's net profit for the first quarter increased 23.01% year-on-year
ZTE's net profit for the first quarter increased by 3.74% year on year; Times Electric's net profit for the first quarter increased by 30.44% year on year.
Xiansheng Pharmaceutical (02096.HK) spent HK$9.5 million to buy back 1.816 million shares on April 25
Gelonghui, April 25 | Xiansheng Pharmaceutical (02096.HK) announced that it spent HK$9.5 million to buy back 1.816 million shares on April 25.
Simcere Pharmaceutical' Profit Down 23% in 2023
Simcere Pharmaceutical Group (HKG:2096) recorded a 23% decline in attributable profit for the year ended Dec. 31, 2023, to 714.8 million yuan from 930.9 million yuan during the year-ago period, accord
Repurchase Collection on April 24 | HSBC Holdings, Hang Seng Bank, etc. bought back one after another, of which HSBC Holdings spent HK$82,6392 million
According to HKEx's April 25 disclosure documents, $HSBC Holdings (00005.HK) $ and $Hang Seng Bank (00011.HK) $ repurchased shares. ① $HSBC Holdings (00005.HK) $ repurchased 1,285,200 common shares on April 23, involving an amount of HK$82,6392 million. The repurchase price per share ranged from HK$64.65 to HK$64.05. ② $Hang Seng Bank (00011.HK) $ repurchased 600,000 common shares on April 24, involving an amount of HK$597.95 million, with a repurchase price of HK$100.3 per share
Changes in US stocks | Zaiding Pharmaceutical rose more than 5%, and the former vice president of Xiansheng Pharmaceutical will join the company as the chief commercial officer in Greater China
On April 24, Gelonghui | Zaiding Pharmaceutical (ZLAB.US) rose more than 5% to $15.88. On April 22, Zhu Tong, the former vice president of Xiansheng Pharmaceutical, joined Zaiding Pharmaceutical as the Chief Commercial Officer of Greater China. Liang Yi, the current Chief Commercial Officer and President of Greater China, will leave office on April 30. Zaiding Pharmaceutical has confirmed the news to the media. According to data, Zhu Tong has extensive experience in pharmaceutical marketing and has worked for well-known multinational pharmaceutical companies such as AstraZeneca, Roche, and Sanofi.
No Data